Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
855.00    5.50 (0.65%)
Bid:
854.00
Ask:
857.00
Spread: 3.00 (0.351%)
Market Cap: £984.74m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Workday Partner Status Update

29 Jul 2022 07:00

RNS Number : 1515U
Kainos Group plc
29 July 2022
 

29 July 2022

 

RNS Reach

 

Kainos Group plc

 

("Kainos" or the "Company")

 

Workday Partner Status Update

 

Kainos Group plc (KNOS), a leading IT provider, operating across two specialist business areas, Digital Services and its Workday Practice, is pleased to announce its appointment as a Workday Phase 1 Prime Status Partner in the US.

 

Kainos is a full-service partner of Workday, experienced in complex deployment and integrations and trusted by customers to launch, test, expand and safeguard Workday systems.

 

This appointment, which is effective immediately, means that Kainos is now a Phase 1 partner in all major European and North American markets.

 

Commenting on this latest development, Malachy Smith, Director for the Workday Practice in Kainos said:

 

"We are delighted with this appointment as it emphasises our global scale and capability. We have been active for several years in North America, building a team of 350 colleagues who are supporting our existing customers in North America.

 

This is also an exciting opportunity for us - the majority of Workday's customers are headquartered in North America. We look forward to working with new and existing Workday customers, helping them maximise the benefits of their investment in the market-leading Workday technology."

 

Ends

 

 

About Kainos

Kainos Group plc is a UK-headquartered provider, operating in two specialist divisions, Digital Services and its Workday Practice.

Our Digital Services division develops and supports custom digital service platforms for public sector, commercial and healthcare customers. Our solutions transform the delivery of these services, ensuring they are secure, accessible and cost effective, and that they provide better outcomes for users.

Kainos has more than 2,500 people across Europe, North America, and South America. Kainos is listed on the London Stock Exchange (LSE: KNOS).

For further information, please visit www.kainos.com. 

 

 

 

 

 

For further information, please contact:

 

Kainos via FTI Consulting LLPBrendan Mooney, Chief Executive OfficerRichard McCann, Chief Financial Officer

 

Investec Bank plc  +44 20 7597 5970Patrick Robb / Ben Griffiths

 

Canaccord Genuity  +44 20 7523 4606Simon Bridges / Andrew Potts

 

FTI Consulting LLP  +44 20 3727 1000Matt Dixon / Dwight Burden / Kwaku Aning

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABUGDRCSDDGDI
Date   Source Headline
1st Mar 201610:00 amRNSDirector/PDMR Shareholding
11th Feb 20166:09 pmRNSDirector/PDMR Shareholding
1st Feb 20167:00 amRNSInvestment in Cirdan Imaging Limited
27th Jan 201611:32 amRNSDirector/PDMR Shareholding
29th Dec 20152:59 pmRNSDirector/PDMR Shareholding
23rd Dec 201511:06 amRNSTransfer of Shares
21st Dec 201510:00 amRNSDisposal of investment in SpeechStorm Limited
18th Dec 20152:42 pmRNSDirector/PDMR Shareholding
17th Dec 20154:46 pmRNSDirector/PDMR Shareholding
23rd Nov 20157:00 amRNSInterim Results
30th Sep 201512:27 pmRNSDirector/PDMR Shareholding
15th Sep 20155:54 pmRNSDirector/PDMR Shareholding
9th Sep 20155:27 pmRNSDirector/PDMR Shareholding
7th Sep 20159:00 amRNSNotice of Results
25th Aug 20158:00 amRNSNew Mobile-Enabled healthcare platform
24th Aug 20155:31 pmRNSDirector/PDMR Shareholding
6th Aug 20157:00 amRNSHolding(s) in Company
16th Jul 20159:05 amRNSDirector/PDMR Shareholding
10th Jul 20157:00 amRNSAdmission to trading on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.